COLLABORATION AND DEVELOPMENT AgreementCollaboration and Development Agreement • April 19th, 2023 • California
This Collaboration Agreement (“Agreement”) is made as of July 5, 2018 (the “Effective Date”) by and between Ampersand Biopharmaceuticals, Inc, a Delaware corporation with offices located at 2545 W. Hillcrest Dr., Thousand Oaks, CA 91320 (“Ampersand”), and Zander Therapeutics, Inc. a Nevada corporation, with offices located at 4700 Spring Street, Suite 304 La Mesa, CA, 91942, USA (“Zander”). Ampersand and Zander are sometimes referred to in this Agreement individually as a “Party”, and collectively as the “Parties”.
BACKGROUNDCollaboration and Development Agreement • April 20th, 2005 • Valera Pharmaceuticals Inc • Pharmaceutical preparations • New York
COLLABORATION AND DEVELOPMENT AGREEMENTCollaboration and Development Agreement • December 12th, 2007 • Indevus Pharmaceuticals Inc • Pharmaceutical preparations • New York
Collaboration and Development Agreement (this “AGREEMENT”) made as of April 6, 2005, by and between VALERA PHARMACEUTICALS, INC., a Delaware corporation, with its principal offices at 8 Clarke Drive, Cranbury, New Jersey 08512 (“Valera”) and ALPEX PHARMA S.A., a Switzerland Societe Anonyme with its principal offices at via Cantonale, Mezzovico-Vira, Switzerland (“Alpex”). Valera and Alpex are sometimes referred to herein individually as a “Party” and collectively as the “Parties”).
COLLABORATION AND DEVELOPMENT AGREEMENTCollaboration and Development Agreement • December 17th, 2007 • Interactive Games Inc. • Sporting & athletic goods, nec • Florida
This Collaboration and Development Agreement (the “Agreement”) is between China Nuvo Solar Energy, Inc., a corporation incorporated in the state of [Nevada] (“Nuvo”), and Pioneer Materials, Inc., a corporation incorporated in the state of Delaware (“PMI”). Nuvo and PMI may be collectively referred to in this Agreement as the “Parties” and each may be individually referred to as a “Party” when referred to generally.
